|
Market Closed -
NYSE
23:00:03 29/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 64.72 USD | -9.72% |
|
-12.39% | -23.79% |
| 09-22 | Piper Sandler Companies Announces Appointment of Wendy L. Schoppert to Board of Directors | CI |
| 09-21 | Grail rallies as FDA staff flags no major concerns for multi-cancer test | RE |
Company Valuation: Piper Sandler Companies
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,510 | 1,840 | 2,631 | 4,756 | 5,652 | 4,349 | - | - |
| Change | - | -26.71% | 42.99% | 80.79% | 18.83% | -23.05% | - | - |
| Enterprise Value (EV) 1 | 1,754 | 1,709 | 2,341 | 4,283 | 4,857 | 3,523 | 3,442 | 3,357 |
| Change | - | -2.57% | 37% | 82.93% | 13.4% | -27.47% | -2.29% | -2.46% |
| P/E | 10.9x | - | - | - | 21.5x | 14.1x | 11.9x | - |
| PBR | 2.37x | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | 0.9x | 0.6x | - |
| Capitalization / Revenue | 1.27x | 1.28x | 1.98x | 3.09x | 3.01x | 2.09x | 1.85x | 1.74x |
| EV / Revenue | 0.89x | 1.19x | 1.76x | 2.78x | 2.58x | 1.69x | 1.47x | 1.34x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 3.19x | 6.35x | 11x | 14.1x | 11.8x | 7.61x | 6.32x | 5.6x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.4875 | 0.9125 | 0.85 | 1.375 | 1.925 | 2.185 | 2.02 | 2.36 |
| Rate of return | 1.09% | 2.8% | 1.94% | 1.83% | 2.27% | 3.38% | 3.12% | 3.65% |
| EPS 2 | 4.108 | - | - | - | 3.955 | 4.58 | 5.42 | - |
| Distribution rate | 11.9% | - | - | - | 48.7% | 47.7% | 37.3% | - |
| Net sales 1 | 1,980 | 1,434 | 1,330 | 1,541 | 1,879 | 2,082 | 2,349 | 2,506 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | 550 | 269.2 | 212.9 | 303.7 | 410.7 | 462.9 | 544.4 | 599.5 |
| Net income 1 | - | - | - | - | 281.3 | 317.4 | 367.1 | - |
| Net Debt 1 | -756.3 | -130.9 | -289.4 | -472.8 | -794.4 | -825.9 | -906.6 | -991.3 |
| Reference price 2 | 44.63 | 32.55 | 43.72 | 74.99 | 84.93 | 64.72 | 64.72 | 64.72 |
| Nbr of stocks (in thousands) | 56,251 | 56,526 | 60,174 | 63,422 | 66,545 | 67,194 | - | - |
| Announcement Date | 2/10/22 A | 2/3/23 A | 2/2/24 A | 1/31/25 A | 2/6/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.65x | 1.92x | - | 3.05% | 4.82B | ||
| 12.02x | 8.4x | 13.59x | 2.81% | 57.39B | ||
| 5.14x | - | - | 1.75% | 11.21B | ||
| 18.35x | 3.44x | 11.88x | 2.13% | 9.05B | ||
| 19.5x | 9.55x | 13.36x | 3.82% | 6.01B | ||
| 13.44x | - | - | 7.89% | 5.15B | ||
| 20.11x | 2.23x | 10.61x | 4.48% | 4.3B | ||
| 30.97x | 1.89x | 8.37x | 0.67% | 3.81B | ||
| Average | 16.90x | 4.57x | 11.56x | 3.32% | 12.72B | |
| Weighted average by Cap. | 13.56x | 6.99x | 12.98x | 2.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PIPR Stock
- Valuation Piper Sandler Companies
Select your edition
All financial news and data tailored to specific country editions
















